3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Malnutrition
4
Esophageal Neoplasms
3
Head and Neck Neoplasms
2
Weight Loss
1
Stomach Neoplasms
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Nutritional Support
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Muscular Atrophy
1
Lymphoma
1
Hyperphagia
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Digestive System Neoplasms
1
Deglutition Disorders
1
Critical Illness
1
Child Nutrition Disorders
1
Cachexia
1
Interventions
Megestrol Acetate
6
Standard of Care
3
Exercise
3
Physical Therapy Modalities
2
Nutrition Assessment
2
Infliximab
2
Blood Specimen Collection
2
testosterone enanthate
1
remune
1
ostarine
1
olanzapine-fluoxetine combination
1
irinotecan sucrosofate
1
clazakizumab
1
bermekimab
1
anamorelin
1
Sodium Chloride
1
Radiotherapy
1
Preoperative Exercise
1
Powders
1
Pentoxifylline
1
Olanzapine
1
Nandrolone Decanoate
1
Mirtazapine
1
Melatonin
1
Megestrol
1
Immunologic Techniques
1
Ibuprofen
1
High-Energy Shock Waves
1
Ghrelin
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cachexia
×
Enteral Nutrition
×
Clear all
NCT02400398
2020-08-11
PanCax
Cedars-Sinai Medical Center
Completed
30 enrolled